Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Gemini: Snapping up SNPs

Gemini: Snapping up SNPs

Gemini Genomics plc is looking to link up with SNP providers to demonstrate medically significant associations between human SNPs and risk factors for a range of common diseases. The clinical genomics company today was to announce its first foray into the SNPs arena, with a large-scale target discovery deal with

Read the full 548 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE